RGEN: Repligen Corp.
About
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Current Value
$148.641 Year Return
Current Value
$148.641 Year Return
Key Details
Market Cap
$8.43B
P/E Ratio
-1022.84
1Y Stock Return
-6.84%
1Y Revenue Growth
-2.91%
Dividend Yield
0.00%
Price to Book
4.2
Strategies that include RGEN
Stock's related to RGEN
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DHR | 63.11% | $174.28B | +8.63% | 0.44% |
| TMO | 56.48% | $202.71B | +6.99% | 0.28% |
| BIO | 53.99% | $9.48B | +9.66% | 0.00% |
| A | 53.37% | $40.11B | +8.30% | 0.68% |
| CRL | 50.65% | $10.29B | +0.32% | 0.00% |
| AZTA | 50.34% | $2.15B | -19.05% | 0.00% |
| MTD | 49.78% | $26.57B | +14.15% | 0.00% |
| RVTY | 48.83% | $14.20B | +27.18% | 0.24% |
| WAT | 48.82% | $22.98B | +34.04% | 0.00% |
| AVTR | 48.81% | $14.36B | -1.59% | 0.00% |
| TECH | 47.69% | $12.08B | +16.42% | 0.42% |
| BLFS | 47.38% | $1.26B | +96.75% | 0.00% |
| IQV | 46.86% | $36.62B | -6.70% | 0.00% |
| LGIH | 46.06% | $2.59B | -10.27% | 0.00% |
| BRKR | 45.37% | $8.85B | -12.05% | 0.34% |
| UE | 45.22% | $2.82B | +28.17% | 2.95% |
| GVA | 44.94% | $4.32B | +108.18% | 0.52% |
| TKR | 44.74% | $5.46B | +3.78% | 1.73% |
| SITE | 44.58% | $6.84B | +5.83% | 0.00% |
| UFPI | 43.77% | $8.20B | +18.72% | 0.98% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TTE | -0.01% | $128.80B | -14.71% | 5.81% |
| RDY | 0.05% | $11.93B | +2.39% | 3.33% |
| UUU | -0.07% | $5.04M | 0.00% | 0.00% |
| HESM | -0.09% | $3.85B | +12.54% | 7.11% |
| AJG | -0.12% | $67.57B | +24.40% | 0.58% |
| IBKR | 0.12% | $20.22B | +134.33% | 0.45% |
| SNY | 0.15% | $120.24B | +2.00% | 4.23% |
| GIS | -0.16% | $37.20B | +3.17% | 3.55% |
| QD | -0.23% | $404.47M | +68.57% | 0.00% |
| TH | -0.27% | $800.43M | -25.92% | 0.00% |
| HRZN | 0.27% | - | - | 14.09% |
| COR | 0.29% | $48.29B | +22.63% | 0.82% |
| HQY | 0.30% | $8.88B | +47.21% | 0.00% |
| AVDL | 0.32% | $1.12B | -11.59% | 0.00% |
| GEL | 0.40% | $1.46B | -5.18% | 5.13% |
| KMB | 0.41% | $46.54B | +12.39% | 3.48% |
| TCPC | 0.42% | - | - | 14.53% |
| MOMO | 0.44% | $923.05M | +12.40% | 0.00% |
| JRVR | -0.45% | $170.61M | -51.92% | 4.45% |
| ASPS | 0.46% | $22.14M | -81.89% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SRPT | -17.32% | $12.22B | +48.57% | 0.00% |
| PGR | -14.99% | $154.68B | +61.58% | 0.43% |
| QXO | -13.40% | $7.09B | -79.19% | 0.00% |
| MRK | -12.44% | $254.51B | -4.24% | 3.06% |
| LUMO | -11.58% | $37.88M | +41.29% | 0.00% |
| CBOE | -11.56% | $22.18B | +16.57% | 1.10% |
| TMUS | -10.94% | $284.11B | +60.22% | 1.15% |
| MCK | -10.73% | $78.87B | +35.27% | 0.43% |
| PULM | -10.11% | $23.16M | +215.42% | 0.00% |
| TCTM | -8.90% | $7.90M | -31.31% | 0.00% |
| PG | -7.78% | $423.20B | +18.18% | 2.21% |
| CHD | -6.94% | $27.25B | +16.97% | 1.02% |
| SOC | -6.69% | $1.91B | +72.84% | 0.00% |
| ROOT | -6.66% | $1.50B | +701.53% | 0.00% |
| ABEO | -6.42% | $275.61M | +36.64% | 0.00% |
| NNE | -5.68% | $924.09M | +600.00% | 0.00% |
| CYCN | -5.59% | $6.34M | +3.08% | 0.00% |
| ACGL | -5.51% | $37.36B | +27.37% | 0.00% |
| BP | -5.43% | $76.97B | -18.54% | 6.21% |
| NHTC | -5.23% | $62.40M | +1.12% | 14.81% |
ETF's related to RGEN
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBMF | 0.13% | $1.04B | 0.85% |
| SGOV | 0.20% | $27.99B | 0.09% |
| DBA | 0.27% | $787.55M | 0.93% |
| PDBC | -0.29% | $4.39B | 0.59% |
| XHLF | 0.55% | $900.10M | 0.03% |
| TBLL | 0.58% | $1.94B | 0.08% |
| TPMN | -0.64% | $40.42M | 0.65% |
| IBDP | 0.70% | $2.03B | 0.1% |
| GSG | 0.74% | $932.06M | 0.75% |
| COMT | -0.83% | $839.86M | 0.48% |
| DBC | 1.90% | $1.39B | 0.87% |
| GBIL | 1.95% | $5.68B | 0.12% |
| GCC | 2.00% | $136.27M | 0.55% |
| USCI | 2.01% | $188.19M | 1.07% |
| BTF | 2.06% | $55.64M | 1.24% |
| DBE | -2.17% | $50.22M | 0.77% |
| BITO | 2.18% | $2.72B | 0.95% |
| DEFI | 2.54% | $14.31M | 0.94% |
| HIGH | 2.54% | $302.94M | 0.52% |
| JUCY | 2.93% | $325.86M | 0.6% |
News
SeekingAlpha
Global markets advanced during the third quarter of 2024, with all regions posting gains. Click here to read the full commentary.
SeekingAlpha
Amidst this environment, the portfolio underperformed the Russell Midcap Growth Index in the third quarter.
SeekingAlpha
The Global Equity ADR composite rose 5.3% gross of fees in the third quarter of 2024, trailing the 6.7% gain in the MSCI ACWI Index. Click here to read the full commentary.
SeekingAlpha
AI chipmaker Nvidia has easily been the best-performing stock over the last twenty years, and it has made a large number of investors extremely wealthy.
SeekingAlpha
Maravai LifeSciences had a rough month, but insider buying raises interest. Read why MRVI stock could be a turnaround play despite recent struggles.
Yahoo
As the U.S. stock market reaches new heights, with the Dow Jones Industrial Average closing at a record high and major indices posting weekly gains, investors are increasingly on the lookout for opportunities that may be trading below their intrinsic value. In this environment of rising markets and economic optimism, identifying undervalued stocks can offer potential entry points for those seeking to capitalize on discrepancies between current prices and perceived true worth.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.